What happens when we modify mosquitoes for disease prevention?

Detalhes bibliográficos
Autor(a) principal: Nazareth, Teresa
Data de Publicação: 2020
Outros Autores: Craveiro, Isabel, Moutinho, Alanny, Seixas, Gonçalo, Gonçalves, Cátia, Gonçalves, Luzia, Teodósio, Rosa, Sousa, Carla A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/93115
Resumo: The release of modified mosquitoes to suppress/replace vectors constitutes a promising tool for vector control and disease prevention. Evidence regarding these innovative modification techniques is scarce and disperse. This work conducted a systematic review, gathering and analysing research articles from PubMed and Biblioteca Virtual em Saúde databases whose results report efficacy and non-target effects of using modified insects for disease prevention, until 2016. More than 1500 publications were screened and 349 were analysed. Only 12/3.4% articles reported field-based evidence and 41/11.7% covered modification strategies’ post-release efficacy. Variability in the effective results (90/25.7%) questioned its reproducibility in different settings. We also found publications reporting reversal outcomes 38/10.9%, (e.g. post-release increase of vector population). Ecological effects were also reported, such as horizontal transfer events (54/15.5%), and worsening pathogenesis induced by natural wolbachia (10/2.9%). Present work revealed promising outcomes of modifying strategies. However, it also revealed a need for field-based evidence mainly regarding epidemiologic and long-term impact. It pointed out some eventual irreversible and important effects that must not be ignored when considering open-field releases, and that may constitute constraints to generate the missing field evidence. Present work constitutes a baseline of knowledge, offering also a methodological approach that may facilitate future updates.
id RCAP_beb2cec9cb5d245567c3f633ec0fcc52
oai_identifier_str oai:run.unl.pt:10362/93115
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling What happens when we modify mosquitoes for disease prevention?a systematic reviewGenetically modified mosquitoesTransgenesisVector-borne diseasesWolbachiaParasitologyEpidemiologyInfectious DiseasesSDG 3 - Good Health and Well-beingThe release of modified mosquitoes to suppress/replace vectors constitutes a promising tool for vector control and disease prevention. Evidence regarding these innovative modification techniques is scarce and disperse. This work conducted a systematic review, gathering and analysing research articles from PubMed and Biblioteca Virtual em Saúde databases whose results report efficacy and non-target effects of using modified insects for disease prevention, until 2016. More than 1500 publications were screened and 349 were analysed. Only 12/3.4% articles reported field-based evidence and 41/11.7% covered modification strategies’ post-release efficacy. Variability in the effective results (90/25.7%) questioned its reproducibility in different settings. We also found publications reporting reversal outcomes 38/10.9%, (e.g. post-release increase of vector population). Ecological effects were also reported, such as horizontal transfer events (54/15.5%), and worsening pathogenesis induced by natural wolbachia (10/2.9%). Present work revealed promising outcomes of modifying strategies. However, it also revealed a need for field-based evidence mainly regarding epidemiologic and long-term impact. It pointed out some eventual irreversible and important effects that must not be ignored when considering open-field releases, and that may constitute constraints to generate the missing field evidence. Present work constitutes a baseline of knowledge, offering also a methodological approach that may facilitate future updates.Global Health and Tropical Medicine (GHTM)Vector borne diseases and pathogens (VBD)Instituto de Higiene e Medicina Tropical (IHMT)Population health, policies and services (PPS)NOVA School of Business and Economics (NOVA SBE)RUNNazareth, TeresaCraveiro, IsabelMoutinho, AlannySeixas, GonçaloGonçalves, CátiaGonçalves, LuziaTeodósio, RosaSousa, Carla A.2020-02-20T23:52:06Z2020-02-112020-02-11T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article18application/pdfhttp://hdl.handle.net/10362/93115engPURE: 16953803https://doi.org/10.1080/22221751.2020.1722035info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:41:37Zoai:run.unl.pt:10362/93115Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:37:41.528692Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv What happens when we modify mosquitoes for disease prevention?
a systematic review
title What happens when we modify mosquitoes for disease prevention?
spellingShingle What happens when we modify mosquitoes for disease prevention?
Nazareth, Teresa
Genetically modified mosquitoes
Transgenesis
Vector-borne diseases
Wolbachia
Parasitology
Epidemiology
Infectious Diseases
SDG 3 - Good Health and Well-being
title_short What happens when we modify mosquitoes for disease prevention?
title_full What happens when we modify mosquitoes for disease prevention?
title_fullStr What happens when we modify mosquitoes for disease prevention?
title_full_unstemmed What happens when we modify mosquitoes for disease prevention?
title_sort What happens when we modify mosquitoes for disease prevention?
author Nazareth, Teresa
author_facet Nazareth, Teresa
Craveiro, Isabel
Moutinho, Alanny
Seixas, Gonçalo
Gonçalves, Cátia
Gonçalves, Luzia
Teodósio, Rosa
Sousa, Carla A.
author_role author
author2 Craveiro, Isabel
Moutinho, Alanny
Seixas, Gonçalo
Gonçalves, Cátia
Gonçalves, Luzia
Teodósio, Rosa
Sousa, Carla A.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Global Health and Tropical Medicine (GHTM)
Vector borne diseases and pathogens (VBD)
Instituto de Higiene e Medicina Tropical (IHMT)
Population health, policies and services (PPS)
NOVA School of Business and Economics (NOVA SBE)
RUN
dc.contributor.author.fl_str_mv Nazareth, Teresa
Craveiro, Isabel
Moutinho, Alanny
Seixas, Gonçalo
Gonçalves, Cátia
Gonçalves, Luzia
Teodósio, Rosa
Sousa, Carla A.
dc.subject.por.fl_str_mv Genetically modified mosquitoes
Transgenesis
Vector-borne diseases
Wolbachia
Parasitology
Epidemiology
Infectious Diseases
SDG 3 - Good Health and Well-being
topic Genetically modified mosquitoes
Transgenesis
Vector-borne diseases
Wolbachia
Parasitology
Epidemiology
Infectious Diseases
SDG 3 - Good Health and Well-being
description The release of modified mosquitoes to suppress/replace vectors constitutes a promising tool for vector control and disease prevention. Evidence regarding these innovative modification techniques is scarce and disperse. This work conducted a systematic review, gathering and analysing research articles from PubMed and Biblioteca Virtual em Saúde databases whose results report efficacy and non-target effects of using modified insects for disease prevention, until 2016. More than 1500 publications were screened and 349 were analysed. Only 12/3.4% articles reported field-based evidence and 41/11.7% covered modification strategies’ post-release efficacy. Variability in the effective results (90/25.7%) questioned its reproducibility in different settings. We also found publications reporting reversal outcomes 38/10.9%, (e.g. post-release increase of vector population). Ecological effects were also reported, such as horizontal transfer events (54/15.5%), and worsening pathogenesis induced by natural wolbachia (10/2.9%). Present work revealed promising outcomes of modifying strategies. However, it also revealed a need for field-based evidence mainly regarding epidemiologic and long-term impact. It pointed out some eventual irreversible and important effects that must not be ignored when considering open-field releases, and that may constitute constraints to generate the missing field evidence. Present work constitutes a baseline of knowledge, offering also a methodological approach that may facilitate future updates.
publishDate 2020
dc.date.none.fl_str_mv 2020-02-20T23:52:06Z
2020-02-11
2020-02-11T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/93115
url http://hdl.handle.net/10362/93115
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PURE: 16953803
https://doi.org/10.1080/22221751.2020.1722035
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 18
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137993467887616